Facing the ongoing challenge of the COVID flu, the Frequency Research Foundation introduces the COVID Flu Frequency Set Version 2.1. This product is our answer to the persistent waves of COVID flu that continue to affect global health, as highlighted in our recent insights. They are free as a public health service.
Distinctive Features:
- Added the COVID Flu June 2024 which is now infecting people globally. This is a particularly exhausting flu which goes on for weeks unless treated with frequencies. It is very infectious and you can get reinfected multiple times.
- Includes ACIRD (Acute Canine Infectious Respiratory Disease) which is actually the COVID flu of 3 Feb 2023 that is infecting dogs and humans alike even in 2024. Also added the COVID Flu March 2024 which is now infecting people everywhere.
- Comprehensive Frequency Scripts: Developed to address the complex nature of the COVID flu as seen in 2023, our scripts target not just the flu viruses but also multiple strains of COVID and a variety of other pathogens including parasites, bacteria, fungi, and mycoplasma.
- Precision and Reliability: Leveraging two decades of research, our frequencies offer a precise and reliable solution to the persistent nature of the COVID flu.
- User-Friendly: Accessible to both healthcare professionals and individuals, enabling effective management of COVID flu symptoms with ease.
Key Benefits:
- Versatile and Effective: This frequency set is uniquely prepared to combat the robust and persistent nature of the COVID flu, as observed globally.
- Support for Rife Practitioners: In recognizing the public health crisis, we’re releasing these frequencies to assist experienced Rife practitioners.
- Comprehensive Coverage: Addressing the full spectrum of the COVID flu’s pathology, the set provides a holistic approach to treatment.
Embrace Advanced Flu Management
With the COVID Flu Frequency Set Version 2.0, step into a new era of managing respiratory health challenges. This product embodies our commitment to innovative, effective solutions in the face of evolving global health challenges.
